What is the purpose of the exclusive conformance requirement for sequence presentation?
The exclusive conformance requirement for sequence presentation in patent applications serves a specific purpose. According to MPEP 2412.06:
“This requirement is necessary to minimize any confusion that could result if more than one format for representing sequence data was employed in a given application.”
By enforcing a standardized format for sequence representation, the USPTO aims to:
- Ensure consistency across patent applications
- Facilitate easier review and comparison of sequence data
- Reduce potential misinterpretations or ambiguities in sequence information
- Streamline the patent examination process for biotechnology-related inventions
This requirement applies to all applications filed on or after July 1, 2022, that disclose nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2412.06 - The Requirement For Exclusive Conformance; Sequences Presented In Drawing Figures,
Patent Law,
Patent Procedure